Suppr超能文献

[肉毒杆菌毒素。痉挛性发声障碍(喉外展肌肌张力障碍)的一种新的治疗选择]

[Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].

作者信息

Loven J O, Brøndbo K, Ganes T

机构信息

Ore-nese-halsavdelingen Rikshospitalet, Oslo.

出版信息

Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):841-3.

PMID:8480289
Abstract

Laryngeal dystonia is a condition characterized by involuntary spasms of the laryngeal muscles. In most patients this involves the adductor laryngeal muscles (adductor laryngeal dystonia). Treatment with a variety of therapies, including speech therapy and pharmacotherapy, have led to minimal improvement. Injections of botulinum-toxin (Botox) bilaterally into the vocalis muscles is a new treatment for adductor laryngeal dystonia. Since May 1991 we have treated 23 patients with adductor laryngeal dystonia with botulinum-toxin. In 74% of the patients the voice improved within 24-72 hours, and effect lasted for 2-14 months (average four months). Most of the patients got a breathy voice and a mild sensation of dysphagia during the first week after the injection.

摘要

喉肌张力障碍是一种以喉部肌肉不自主痉挛为特征的病症。在大多数患者中,这涉及喉内收肌(内收型喉肌张力障碍)。包括言语治疗和药物治疗在内的多种治疗方法收效甚微。双侧声带肌注射肉毒杆菌毒素(保妥适)是治疗内收型喉肌张力障碍的一种新方法。自1991年5月以来,我们用肉毒杆菌毒素治疗了23例内收型喉肌张力障碍患者。74%的患者在24至72小时内声音改善,效果持续2至14个月(平均四个月)。大多数患者在注射后的第一周出现声音带呼吸声和轻度吞咽困难感。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验